Decreased nocturnal levels of prolactin and growth hormone in women with fibromyalgia

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 4, 2001, Pages 1672-1678

  Landis, Carol A ^a   Lentz, Martha J ^a   Rothermel, James ^a   Riffle, Stacy C ^a   Chapman, Darla ^a   Buchwald, Dedra ^a   Shaver, Joan L F ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PROLACTIN; SOMATOMEDIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROMYALGIA; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SLEEP WAKING CYCLE;

ADULT; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; FIBROMYALGIA; HUMAN GROWTH HORMONE; HUMANS; MIDDLE AGED; PROLACTIN; REFERENCE VALUES; SLEEP;

EID: 0035039973     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.4.1672     Document Type: Article

References (62)

1. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee
2. The prevalence and characteristics of fibromyalgia in the general population
3. The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia
4. Neuroendocrine abnormalities in fibromyalgia and related disorders
5. Low levels of somatomedin-C in patients with the fibromyalgia syndrome
6. Hypothalamic-pituitary-insulin-like growth factor-1 axis dysfunction in patients with fibromyalgia
7. Disordered growth hormone secretion in fibromyalgia: A review of recent findings and a hypothesized etiology
8. A randomized, double-blind, placebo-controlled study of growth hormone in the teatment of fibromyalgia
9. Low growth hormone secretion in patients with fibromyalgia: A preliminary report on 10 patients and 10 controls
10. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome
11. Human growth hormone release: Relation to slow-wave sleep and sleepwaking cycles
12. The nocturnal rise of human prolactin is dependent on sleep
13. Sleep-related, nyctohemeral and briefly episodic variation in human plasma prolactin concentrations
14. Human growth hormone release in sleep: Nonsuppression by acute hyperglycemia
15. Prolactin secretion and sleep
16. Temporal relationship between prolactin secretion and slow-wave electroencephalic activity during sleep
17. Interrelations between sleep and the somatotropic axis
18. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome
19. Pituitary release of growth hormone and prolactin in primary fibromyalgia syndrome
20. Fibromyalgia and sex hormones
21. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome
22. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain)
23. Neuromediator and hormonal perturbations in fibromyalgia syndrome: Results of chronic stress?
24. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing factors
25. Musculoskeletal symptoms and Non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects
26. Overnight human plasma melatonin, cortisol, prolactin, TSH, under conditions of normal sleep, sleep deprivation, and sleep recovery
27. Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and estradiol in healthy young women
28. Age-dependent suppression of nocturnal growth hormone levels during sleep deprivation
29. Sleep, psychological distress, and stress arousal in women with fibromyalgia
30. Sleep in fibromyalgia patients: Subjective and objective findings
31. Physical activity as an index of heart attack risk in college alumni
32. Comparison of methods to measure physical activity in postmenopausal women
33. An inventory for measuring depression
34. Psychometric properties of the Beck Depression Inventory: 25 years of evaluation
35. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniqures in clinical research
36. The treatment of restless legs syndrome and periodic limb movement disorder
37. Establishment and implementation of standardized laboratory data collection and scoring procedures
38. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
39. Prolactin pulsatile characteristics in postmemopausal women
40. Elements in the pathophysiology of dimished growth hormone (GH) secretion in aging humans
41. Nocturnal secretion of prolactin and cortisol and the sleep EEG in patients with major endogenous depression during an acute episode and after full remission
42. The 24-hour profile of plasma prolactin in men with major endogenous depressive illness
43. Prolactin in patients with major depressive disorder and in healthy subjects. II. Longitudinal study of basal prolactin and post-TRH-stimulated prolactin levels
44. Twenty-four-hour rhythm of prolactin in depressive patients
45. Age alters pulsatile prolactin release: Influence of dopaminergic inhibition
46. Sleep-related growth hormone secretion is persistently suppressed in women with recurrent depression: A preliminary longitudinal analysis
47. 24-Hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: Effect of antidepressant treatment
48. The sleep EEG and nocturnal hormonal secretion studies on changes during the course of depression and on effects of CNS-active drugs
49. Objective sleep quality of healthy older men and women is differentially disrupted by nighttime periodic blood sampling via indwelling catheter
50. Gender differences in the temporal organization of prolactin (PRL) secretion: Evidence for a sleep-independent circadian rhythm of circulating PRL levels-a clinical research center study
51. Effects of "jet lag" on hormonal patterns. III. Demonstration of an intrinsic circadian rhythmicity in plasma prolactin
52. Endocrine and other biological rhythms
53. Prolactin: Basic physiology
54. Mechanisms subserving the physiological nocturnal relative hypoprolactinemia of healthy older men: Dual decline in prolactin secretory burst mass and basal release with preservation of pulse duration, frequency, and interpulse interval-a general clinical research center study
55. Sleep and other symptoms in primary, fibromyalgia and in healthy controls
56. Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome
57. Prolactin in cluster headache: Diurnal secretion, response to thyrotropin-releasing hormone, and relation fo sex steroids and gonadotropins
58. Attenuated pulsatile release of prolactin in men with insulin-dependent diabetes mellitus
59. Insulin-like growth factor-1 (somato-medin-C) levels in chronic fatigue syndrome and fibromyalgia
60. Nocturnal wakefulness inhibits growth hormone (GH)-releasing hormone-induced GH secretion